Home/ Stocks/ PLRX

Pliant Therapeutics, Inc. Common Stock

PLRX XNAS

$0.81 -0.01 (-0.75%) ▼ 15-min delayed

Open

$0.81

High

$0.82

Low

$0.80

Volume

151.6K

Market Cap

$50.14M

About Pliant Therapeutics, Inc. Common Stock

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 49 Website →

Related Market News

No specific coverage for PLRX yet. Check out our latest market news or earnings calendar.

Get PLRX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Pliant Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.